HALOZYME THERAPEUTICS, INC.

HALOCIK 0001159036 · Every Form 4 filed by insiders at this issuer.

Filings

19

Latest Mar 26, 2024

Unique insiders

4

Showing

19 of 19

Page 1

Top insiders

Most active reporters at HALOZYME THERAPEUTICS, INC.

NameRolesFilings
LaBarre Michael J.
Officer
8
LaBrosse Nicole
Officer
4
Torley Helen
OfficerDirector
4
Snyder Mark Howard
Officer
3

All filings

19 Form 4 / 4-A filings, newest first

FiledInsiderTop transactionSharesPriceValue
Mar 26, 2024
LaBarre Michael J.
SVP, CHIEF TECHNICAL OFFICER
M8,436$12.07$101,823
Mar 13, 2024
LaBarre Michael J.
SVP, CHIEF TECHNICAL OFFICER
S10,000$42.273$422,730
Feb 28, 2024
LaBarre Michael J.
SVP, CHIEF TECHNICAL OFFICER
S10,000$39.946$399,460
Feb 27, 2024
Torley Helen
PRESIDENT AND CEO · Director
Holdings only
Feb 27, 2024
LaBrosse Nicole
SVP, CHIEF FINANCIAL OFFICER
Holdings only
Feb 27, 2024
Snyder Mark Howard
SVP, GENERAL COUNSEL
Holdings only
Feb 27, 2024
LaBarre Michael J.
SVP, CHIEF TECHNICAL OFFICER
Holdings only
Feb 20, 2024
Torley Helen
PRESIDENT AND CEO · Director
F11,292$36.10$407,641
Feb 20, 2024
LaBrosse Nicole
SVP, CHIEF FINANCIAL OFFICER
F2,864$36.10$103,390
Feb 20, 2024
Snyder Mark Howard
SVP, GENERAL COUNSEL
F2,577$36.10$93,030
Feb 20, 2024
LaBarre Michael J.
SVP, CHIEF TECHNICAL OFFICER
F3,097$36.10$111,802
Feb 16, 2024
Torley Helen
PRESIDENT AND CEO · Director
F17,619$35.91$632,698
Feb 16, 2024
LaBrosse Nicole
SVP, CHIEF FINANCIAL OFFICER
F686$35.91$24,634
Feb 16, 2024
LaBarre Michael J.
SVP, CHIEF TECHNICAL OFFICER
F3,832$35.91$137,607
Feb 13, 2024
Torley Helen
PRESIDENT AND CEO · Director
F16,943$35.49$601,307
Feb 13, 2024
LaBrosse Nicole
SVP, CHIEF FINANCIAL OFFICER
F1,477$35.49$52,419
Feb 13, 2024
LaBarre Michael J.
SVP, CHIEF TECHNICAL OFFICER
F2,901$35.49$102,956
Jan 18, 2024
LaBarre Michael J.
SVP, CHIEF TECHNICAL OFFICER
S10,000$36.00$360,000
Jan 5, 2024
Snyder Mark Howard
SVP, GENERAL COUNSEL
F2,957$35.78$105,801

Showing 119 of 19

Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.